Search
for
Sort by
Research 481–510 of 1000+
- Interferon in the treatment of cutaneous T-cell lymphoma
- Medical and surgical therapies for alopecias in black women
- Acne-associated syndromes: models for better understanding of acne pathogenesis
- Hyaluronidase Modulates Inflammatory Response and Accelerates the Cutaneous Wound Healing
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Reproductive seasonality and maturation throughout the complete life-cycle in the mouflon ram (Ovis musimon)
- Tinea Capitis: An Overview with Emphasis on Management
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management
- Cell Types Promoting Goosebumps Form a Niche to Regulate Hair Follicle Stem Cells
- Methotrexate in dermatology
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Infertility in Polycystic Ovary Syndrome: Focus on Low-Dose Gonadotropin Treatment
- Endocrine Influences on Hair Growth
- Folliculitis decalvans: a multicentre review of 82 patients
- Telogen effluvium
- Management of congenital ichthyoses: European guidelines of care, part two
- The cycling hair follicle as an ideal systems biology research model
- Efficacy and safety of mycophenolate mofetil for lichen planopilaris
- THE DISEASE SPECTRUM, EPIDEMIOLOGY, AND ETIOLOGY OF TOXIC-SHOCK SYNDROME
- Interventions for nail psoriasis
- Amendments to Organizational Theorizing.
- Zinc as an ambivalent but potent modulator of murine hair growth in vivo- preliminary observations
- Temporal Variations of Skin Pigmentation in C57Bl/6 Mice Affect Optical Bioluminescence Quantitation
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Female Pattern Hair Loss
- Nonclassic adrenal hyperplasia
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*